Cost of Tuberculosis in Childhood
- Corresponding Author:
- Reka Bodnar
Department of Pharmacy Administration
Semmelweis University, Budapest, Hungary
Tel/Fax: +36 (1) 216-1571
E-mail: [email protected]
Received Date: November 07, 2011; Accepted Date: November 18, 2011; Published Date: December 11, 2011
Citation: Bodnar R, Kadar L, Somoskovi A, Meszaros A (2011) Cost of Tuberculosis in Childhood. Mycobact Diseases 1:102. doi:10.4172/2161-1068.1000102
Copyright: © 2011 Bodnar R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Background: Cost of management of tuberculosis (TB) has high expenses from both patient and health insurance perspective.
Methods: A systematic review on cost analysis of TB in children was executed in Ovid-MEDLINE for the period 1991-2011. Search terms were tuberculosis, cost and childhood. Review articles, commentaries, letters were excluded.
Results: The first search resulted 156 articles, after linguistic and content screening 16 articles were considered for further analysis. The topics related to the cost-analysis were latent tuberculosis infection, BCG vaccination, cost-effectiveness of TB control program, TB screening, extrapulmonary TB, TB in resource rich and resource poor countries.
Conclusion: After processing the results of the articles, it was identified that tuberculosis screening among schoolchildren and kindergarteners as well as BCG revaccination is not cost-effective in low-burden countries.